Scientists in the United States claimed a potential breakthrough in Covid-19 treatment on Wednesday with patients effectively responding to an antiviral drug during a trial.
The clinical trial of the drug remdesivir showed that patients recovered about 30 percent faster than those on a placebo.
The trial’s findings were also verified by the top US epidemiologist, Anthony Fauci, who oversaw the study.
Briefing reporters at the White House, Fauci said, “The data shows that remdesivir has a clear-cut, significant, positive effect in diminishing the time to recovery.”
The remdesivir trial – involving 1,063 people from different global locations in the US, Europe, and Asia – showed the drug successfully blocking the virus.
It’s pertinent to note that remdesivir trials had failed against the Ebola virus. Also, a smaller WHO study of the drug, performed in China’s pandemic epicenter Wuhan, found little effects on patients.
A comment on this major development from the World Health Organization is still awaited as its senior official declined to weigh in saying he was yet to review the complete study.
The virus has infected over 3.2 million and killed more than 228,000 worldwide. The successful clinical trial of remdesivir has fuelled hopes for a return to normal from the unrelenting crisis.